Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?
- PMID: 16265064
- DOI: 10.1038/ncpgasthep0051
Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?
Comment on
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691. N Engl J Med. 2004. PMID: 15175435 Clinical Trial.